The occurrence and significance of V gene mutations in B cell-derived human malignancy.
about
Chronic Lymphocytic Leukemia: Exploiting Vulnerabilities with Targeted AgentsThe outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergyComprehensive assessment of potential multiple myeloma immunoglobulin heavy chain V-D-J intraclonal variation using massively parallel pyrosequencing.Plant virus particles carrying tumour antigen activate TLR7 and Induce high levels of protective antibody.Somatic hypermutation patterns in germinal center B cell malignancies.Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice.Exome Sequencing in Classic Hairy Cell Leukaemia Reveals Widespread Variation in Acquired Somatic Mutations between Individual Tumours Apart from the Signature BRAF V(600)E Lesion.Mechanisms of B-cell lymphoma pathogenesis.Molecular pathogenesis of chronic lymphocytic leukemia.Protein arginine methyltransferase 5 (PRMT5) inhibition induces lymphoma cell death through reactivation of the retinoblastoma tumor suppressor pathway and polycomb repressor complex 2 (PRC2) silencing.Molecular insight into the biology and clinical course of hairy cell leukemia utilizing immunoglobulin gene analysis.Insight into the behavior of hairy cell leukemia by immunogenetic analysis.Hairy cell leukaemia: biological and clinical overview from immunogenetic insights.Splenic marginal-zone lymphoma: ontogeny and genetics.Catalog of genetic progression of human cancers: non-Hodgkin lymphoma.Biologic prognostic markers and their application in clinical trials and management of chronic lymphocytic leukaemia patients.Differential DNA methylation patterns of small B-cell lymphoma subclasses with different clinical behavior.Molecular analysis of immunoglobulin genes reveals frequent clonal relatedness in double monoclonal gammopathies.Immunoglobulin gene repertoire in chronic lymphocytic leukemia: insight into antigen selection and microenvironmental interactions.Indications for peripheral light-chain revision and somatic hypermutation without a functional B-cell receptor in precursors of a composite diffuse large B-cell and Hodgkin's lymphoma.Clues to pathogenesis of Waldenström macroglobulinemia and immunoglobulin M monoclonal gammopathy of undetermined significance provided by analysis of immunoglobulin heavy chain gene rearrangement and clustering of B-cell receptors.Gene-targeted mice lacking the Ung uracil-DNA glycosylase develop B-cell lymphomas.Incidence of novel N-glycosylation sites in the B-cell receptor of lymphomas associated with immunodeficiency.Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.Clonally related splenic marginal zone lymphoma and Hodgkin lymphoma with unmutated V gene rearrangements and a 15-yr time gap between diagnoses.Molecular histogenesis of plasmablastic lymphoma of the oral cavityLack of allelic exclusion by secondary rearrangements of tumour B-cell receptor light chains in hairy cell leukaemiaIncidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma
P2860
Q26764833-4B7D2E86-B58E-41F8-B333-C9605FE17BECQ26865760-F7D62D00-4874-46AF-A1D4-CE23CD18F08BQ34241312-A0DDE3CA-05A4-42EE-81A8-4D8AD7748B06Q35096289-DC03E400-7F94-42D4-A7FB-3E6013ED2500Q35552528-F9C1B043-ED39-48BF-ACC9-64149D4834D6Q35616311-C92400FC-3E1C-4E45-9F91-8DB7758F2CC3Q35922137-06736E5E-5ADC-4D90-8FA1-2F89A4727B29Q36085626-D3330FB6-180E-4AB9-A97F-5E07AC455A5EQ36290321-A82A04CE-ED3B-4495-A4BF-4CCC45501E2CQ37368735-D3E6500C-B1BF-4DA0-8B4C-5AD5CB16EE46Q37816419-29AFF55D-5D0D-4D14-92B3-28FA240E981BQ37866773-20CCFCC1-9859-4F80-A06E-6EEC9F145C4BQ37889776-A13EE13D-D136-4E9B-AF6D-AB97C0A5E863Q38209575-64570564-4D46-4AB3-8B39-21C77C76E9F7Q38766227-A8DD8B42-2464-4038-9951-6B64E1ADC8EFQ40138593-F12E714A-F03D-4E90-B0D4-32C31DABA9AAQ40245112-082964A0-66F8-463F-AC51-9BDBDE76FC6FQ40288181-22158B1C-9982-47A1-B2B2-98EBE37571D2Q42323395-70FDF91A-CA57-4ED4-925A-4F3448F0EA71Q42616049-CBCE1FC4-D376-4D42-8327-D0F8570EFF5CQ43706086-91EC69BA-6D08-4FFE-9367-CD35A6E50038Q44559497-A592F7BD-C2A4-46F7-907D-1A525F5F1D00Q51052769-2294CC59-31E6-4D4F-A120-14F1B0BCA666Q53093869-7A4E0A4C-F75E-41E7-99E8-F385DC2A2B7BQ54691812-154083CE-C988-431D-955C-396563D9C404Q57279602-1648BFA3-99A6-4A15-AC1B-B2FDF4A0C5AFQ58000956-6359AFF4-994E-4379-8203-E3D9986339A0Q58025679-7A6ECED0-3B74-49C6-A874-03152688781E
P2860
The occurrence and significance of V gene mutations in B cell-derived human malignancy.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The occurrence and significance of V gene mutations in B cell-derived human malignancy.
@ast
The occurrence and significance of V gene mutations in B cell-derived human malignancy.
@en
The occurrence and significance of V gene mutations in B cell-derived human malignancy.
@nl
type
label
The occurrence and significance of V gene mutations in B cell-derived human malignancy.
@ast
The occurrence and significance of V gene mutations in B cell-derived human malignancy.
@en
The occurrence and significance of V gene mutations in B cell-derived human malignancy.
@nl
prefLabel
The occurrence and significance of V gene mutations in B cell-derived human malignancy.
@ast
The occurrence and significance of V gene mutations in B cell-derived human malignancy.
@en
The occurrence and significance of V gene mutations in B cell-derived human malignancy.
@nl
P2093
P1476
The occurrence and significance of V gene mutations in B cell-derived human malignancy.
@en
P2093
Hamblin TJ
Ottensmeier CH
Stevenson FK
P304
P356
10.1016/S0065-230X(01)83004-9
P577
2001-01-01T00:00:00Z